← All trials
NCT05303376
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2022
- Primary completion
- Mar 31, 2023
- Completion date
- Mar 31, 2023
- First posted
- Mar 31, 2022
- Last posted
- Dec 5, 2022
- Enrollment
- 216
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Immune Biosolutions IncLead sponsor
- Immune Biosolutions IncStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.